World's leading clinical conference on bone, joint and muscle health
Programme
Sunday May 7th - CEST Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 130
Psoriatic disease. New therapeutic horizons and the effect on the musculoskeletal system in the era of COVID-19
Chairperson :
Athanassiou Panagiotis
- Psoriatic disease in the era of COVID-19
- Psoriatic disease. Comorbidities
- Psoriatic disease and rehabilitation
- Psoriatic disease. New therapeutic horizons. Small molecule inhibitors, biologic agents and JAK inhibitors
08:00
Room 129
Tobacco harm reduction and bone health
Chairpersons :
Maria Luisa Brandi
& Umberto Tarantino
- Cigarette smoke and bone disorders
- Health lifestyles and bone health: the Case of Tobacco Harm Reduction
- Role of cigarette smoke and tobacco heated products on bone remodeling
08:00
Room 123
Fracture Liaison Service: From Zero to Hero – National experience
Chairpersons :
Yasser El Miedany
& Mathias Toth
- Closing the treatment gap
- How pharmaceutical industry can support national FLS
- Falls: raising awareness through HCP education
08:00
Room 121
Evidence based Latin American guidelines about prevention, diagnosis and treatment of glucocorticoid induced osteoporosis. An update
Chairpersons :
Osvaldo Daniel Messina
& Claudia Campusano
- Guidelines methodology
- Results
- Panel proposal for pharmacological therapies according to fracture risk stratification
08:00
Room 119
Osteoimmunology in the era of COVID-19
Chairperson :
Kostoglou-Athanassiou Ifigenia
- Pandemics through the ages. The role of stress trauma and frailty
- Menopause and osteoimmunology
- Osteoimmunology and current treatment of osteoporosis
- Osteoimmunology. The connection between bone and the immune system
08:00
Room 120
The Current and Future Approaches in the Diagnosis and Management of Sarcopenia
Chairpersons :
Pınar Borman
& Belgin Karaoglan
- What is sarcopenia? How is it diagnosed?
- Sarcopenia and New Biomarkers.
- The Management of Sarcopenia
08:00
Room 122
Update in Musculoskeletal Conditions with Hand involvement
Chairpersons :
Fitnat Dincer
& Andreas Winkelmann
- Degenerative joint disease of Hand, Osteoarthritic Hand
- Hand involvement in Complex Regional Pain Syndrome-CRPS (Sudeck atrophy, osteoporosis in hand)
- Soft tissue lesions / non articular involvement of Hand
08:00 - 09:00
Room 131-132
ESCEO SYMPOSIUM
Update on the role of oral Bisphosphonates in the treatment of osteoporosis
Chairpersons :
Jean-Marc Kaufman
& René Rizzoli
- Risk/benefit ratio of oral Bisphosphonates in the treatment of osteoporosis (fracture reduction, GI, CV, AFF, ONJ,…)
- New formulation of oral Bisphosphonates: Impact on the reduction of osteoporosis treatment gap
- Discussion
08:00 - 09:00
Room 118
SICOT-ESCEO-IOF Symposium
Standards in Management of Osteoporotic Fractures
Chairperson :
Ilir Hasani
- Management of Osteoporotic Spinal Fractures
- Treatment of unstable osteoporotic bimalleolar ankle fractures
- Management of Acetabular fractures in elderly
- Proximal femur fractures in elderly
09:00 - 10:00
Meet-The-Expert Session
09:00
Room 122
Complex cases – questions and answers
09:00
Room 123
High bone mass: what should we do?
09:00
Room 119
Transgender medicine and bone
09:00
Room 120
Dietary patterns and bone health
09:00 - 10:00
Poster Area
Poster Viewing Session III
09:00 - 10:00
Room 130
Educational Lecture organized by OAFI
The beneficial effects of pharmaceutical-grade chondroitin sulfate on cardiovascular system in patients with osteoarthritis
09:00 - 10:00
Room 118
Sponsored Meet-The-Expert Session
10:00 - 12:00
Auditorium A
Scientific Session VII
Chairpersons :
Adolfo Diez-Perez
& Radmila Matijevic
10:00
Auditorium A
Plenary Lecture 9
Do high and very high fracture risk really matter?
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Oral communication selected from abstracts
OC34: LONG-TERM SAFETY OF BUROSUMAB IN ADULTS WITH X-LINKED HYPOPHOSPHATAEMIA (XLH) IN A PHASE 3B OPEN-LABEL STUDY
Presenting author:
Authors:
10:50
Auditorium A
Oral communication selected from abstracts
OC35: HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH TUMOR-INDUCED OSTEOMALACIA: REVIEW OF PATIENT HISTORIES PRIOR TO ENTRY IN CLINICAL TRIAL UX023T-CL201
Presenting author:
Authors:
11:00
Auditorium A
Oral communication selected from abstracts
OC36: A DIETARY PLUS EXERCISE INTERVENTION IMPROVES BONE TURNOVER IN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES
Presenting author:
Authors:
11:10
Auditorium A
Oral communication selected from abstracts
OC37: INTEGRATED LONG-TERM BONE MINERAL DENSITY OUTCOMES IN WOMEN RECEIVING RELUGOLIX COMBINATION THERAPY IN LIBERTY AND SPIRIT STUDIES VS NON-TREATED WOMEN
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC38: ZOLEDRONATE AS A PREVENTATIVE MEASURE FOR BONE LOSS FOLLOWING DENOSUMAB DISCONTINUATION: RESULTS FROM A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
11:30
Auditorium A
Plenary Lecture 10
Management of premenopausal osteoporosis
12:00 - 13:00
Non-Sponsored Symposia
12:00
Room 122
Perioperative bone optimization in the arthroplasty candidate
Chairperson :
Roberto Enrique Lopez Cervantes
- State of the art. What do we know about bone density after arthroplasty?
- The Effect of Antiresorptive on Bone Loss After Arthroplasty. Literature Review and Meta-Analysis of Randomized Controlled Trials
- Periprosthetic BMD loss and its implication in the revision and complication rates
- Statement position proposal of how to do "bone optimization in the arthroplasty candidate"
12:00
Room 123
Link between diabetes, osteoporosis and bone health - rheumatologist, endocrinologist and registered dietitian point of view
Chairperson :
Mislav Radić
- Osteoporosis and bone health in diabetes mellitus
- Nutrition and bone health in diabetes-induced osteoporosis
- Bone health and osteoporosis treatment in diabetes mellitus
12:00
Room 120
Bone health and cancer: A dicey duo
Chairpersons :
Yasser El Miedany
& Naglaa Gadallah
- Addressing Bone Loss in Cancer patients: A step forward
- What Treating Doctors and Breast Cancer Survivors Need to Know About Osteoporosis
- Optimal bone health management strategies in patients with prostate cancer
- Bone health in childhood cancer
12:00
Room 130
Prevention of osteoporotic fractures: the role of exercise and of FRID (falls risk increasing drugs) avoidance
Chairperson :
Ana Paula Barbosa
- The role of post-fracture exercise in women´s physical function and quality of life
- The role of FRID (Falls Risk Increasing Drugs) avoidance
- Q&A
12:00
Room 129
Sarcopenia and rheumatoid arthritis
Chairpersons :
Kostoglou-Athanassiou Ifigenia
& Yannis Dionyssiotis
- Rheumatoid arthritis and muscular involvement
- Sarcopenia and rheumatoid arthritis
- Treatment of sarcopenia in rheumatoid arthritis
12:00
Room 119
Musculoskeletal Functional Capacity in Sub-Saharan Africa
Chairperson :
Ayse Zengin
- Co-morbidities of muscle function in older adults from The Gambia
- Impact of HIV on midlife musculoskeletal health in sub-Saharan Africa
- Markers of low muscle mass and function: insights from proteomics in middle-aged South Africans
- Muscle and functional ability in sub-Saharan Africa: The MUFASSA study
12:00
Room 121
Rare Bone Diseases: A view from LATAM
Chairperson :
Alejandro Román-González
- Welcome and general overview of rare bone diseases in Latin America
- X-LINKED hypophosphatemia (XLH): Diagnosis and treatment in adults
- Transition of care: From childhood to adulthood. How can we improve the care of our patients with endocrine disorders?
- Tumor-induced osteomalacia and fibrodysplasia ossificans progressiva in Colombia and Latin America
- Questions and wrap-up